GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (OTCPK:SIGGF) » Definitions » Cash Flow from Operations

Sigma Healthcare (Sigma Healthcare) Cash Flow from Operations : $28 Mil (TTM As of Jan. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sigma Healthcare Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Jan. 2024, Sigma Healthcare's Cash Receipts from Operating Activities was $1,210 Mil. Its Cash Payments was $-1,176 Mil. Its Dividends Paid was $0 Mil. Its Dividends Received was $0 Mil. Its Interest Paid was $-7 Mil. Its Interest Received was $1 Mil. Its Taxes Refund Paid was $2 Mil. And its Cash Flow from Others was $-0 Mil. In all, Sigma Healthcare's Cash Flow from Operations for the six months ended in Jan. 2024 was $29 Mil.


Sigma Healthcare Cash Flow from Operations Historical Data

The historical data trend for Sigma Healthcare's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma Healthcare Cash Flow from Operations Chart

Sigma Healthcare Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 137.41 9.64 -33.22 99.26 27.85

Sigma Healthcare Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.69 67.14 31.14 -1.14 28.97

Sigma Healthcare Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Sigma Healthcare's Cash Flow from Operations for the fiscal year that ended in Jan. 2024 is calculated as:

Sigma Healthcare's Cash Flow from Operations for the quarter that ended in Jan. 2024 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sigma Healthcare  (OTCPK:SIGGF) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Sigma Healthcare's cash receipts from operating activities for the six months ended in Jan. 2024 was $1,210 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Sigma Healthcare's cash payments for the six months ended in Jan. 2024 was $-1,176 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Sigma Healthcare's cash payments for the six months ended in Jan. 2024 was $0 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Sigma Healthcare's cash payments for the six months ended in Jan. 2024 was $0 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Sigma Healthcare's cash payments for the six months ended in Jan. 2024 was $-7 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Sigma Healthcare's cash payments for the six months ended in Jan. 2024 was $1 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Sigma Healthcare's cash payments for the six months ended in Jan. 2024 was $2 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Sigma Healthcare's cash flow from others for the six months ended in Jan. 2024 was $-0 Mil.


Sigma Healthcare Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Sigma Healthcare (Sigma Healthcare) Business Description

Traded in Other Exchanges
Address
2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.